Cardiac myxosarcoma: A case report.
Myxosarcoma
Transthoracic Echocardiogram (TTE)
Journal
Caspian journal of internal medicine
ISSN: 2008-6164
Titre abrégé: Caspian J Intern Med
Pays: Iran
ID NLM: 101523876
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
entrez:
20
5
2021
pubmed:
21
5
2021
medline:
21
5
2021
Statut:
ppublish
Résumé
It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. Cardiac myxosarcoma is a rare neoplasm that appears to rise from the same cellular source like myxoma. It is difficult to differentiate a myxoma tumor from a myxosarcoma tumor because of its appearance and pathology examination. Myxosercoma tumor requires surgery and chemoradiotherapy, but myxoma is treated only by surgery. We describe a case of a 58-year-old patient with a left atrium myxosarcoma, presenting with congestive heart failure. Transthoracic echocardiogram (TTE) showed a large polypoid and mobile mass in the left atrium, the patient underwent cardiac surgery and the tumor was successfully extracted, and histopathological result revealed typical features of myxoma. 15 days after surgery, he underwent explorative laparatomy because of progressive GI bleeding. Laparatomy revealed extensive metastatic masses in abdomen and the pathology diagnoses was myxosaroma. Unfortunately, in spite of supportive care, the patient expired on postoperative day one. It is difficult to differentiate a myxoma tumor from a myxosarcoma tumor because of its appearance and pathology examination. Maybe magnetic resonance imaging can help us to achieve more data suggesting malignancy.
Sections du résumé
BACKGROUND
BACKGROUND
It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. It is a rare cardiac malignant primary tumor that seems to derive from the same cellular line as myxomas, but the prognosis is very different. Cardiac myxosarcoma is a rare neoplasm that appears to rise from the same cellular source like myxoma. It is difficult to differentiate a myxoma tumor from a myxosarcoma tumor because of its appearance and pathology examination. Myxosercoma tumor requires surgery and chemoradiotherapy, but myxoma is treated only by surgery.
CASE PRESENTATION
METHODS
We describe a case of a 58-year-old patient with a left atrium myxosarcoma, presenting with congestive heart failure. Transthoracic echocardiogram (TTE) showed a large polypoid and mobile mass in the left atrium, the patient underwent cardiac surgery and the tumor was successfully extracted, and histopathological result revealed typical features of myxoma. 15 days after surgery, he underwent explorative laparatomy because of progressive GI bleeding. Laparatomy revealed extensive metastatic masses in abdomen and the pathology diagnoses was myxosaroma. Unfortunately, in spite of supportive care, the patient expired on postoperative day one.
CONCLUSION
CONCLUSIONS
It is difficult to differentiate a myxoma tumor from a myxosarcoma tumor because of its appearance and pathology examination. Maybe magnetic resonance imaging can help us to achieve more data suggesting malignancy.
Identifiants
pubmed: 34012543
doi: 10.22088/cjim.12.2.228
pmc: PMC8111807
doi:
Types de publication
Case Reports
Langues
eng
Pagination
228-231Informations de copyright
Copyright © 2020, Babol University of Medical Sciences.
Références
Ann Thorac Surg. 1993 Sep;56(3):564-6
pubmed: 7691044
Heart Views. 2011 Jan;12(1):35-8
pubmed: 21731808
Surg Today. 2006;36(7):602-7
pubmed: 16794794
J La State Med Soc. 2002 Nov-Dec;154(6):308-12
pubmed: 12517027
Chest. 1975 Jun;67(6):733-5
pubmed: 1126234
Cancer. 1992 Jan 15;69(2):387-95
pubmed: 1728367
Nihon Kokyuki Gakkai Zasshi. 2000 Aug;38(8):622-7
pubmed: 11061089
Anticancer Res. 2003 Jul-Aug;23(4):3549-53
pubmed: 12926105
Histopathology. 1999 Apr;34(4):295-304
pubmed: 10231396
Minerva Chir. 1996 Jul-Aug;51(7-8):585-8
pubmed: 8940803
Mayo Clin Proc. 1979 Apr;54(4):261-6
pubmed: 423607
Asian Cardiovasc Thorac Ann. 2002 Mar;10(1):8-11
pubmed: 12079962
Interact Cardiovasc Thorac Surg. 2005 Aug;4(4):311-5
pubmed: 17670419
Eur J Cardiothorac Surg. 2006 Jun;29(6):925-32
pubmed: 16675225
Cardiovasc Pathol. 2010 Nov-Dec;19(6):343-52
pubmed: 19747857